The multifunctional APE1 DNA repair–redox signaling protein as a drug target in human disease
Author:
Funder
U.S. Department of Defense
Riley Children's Foundation
National Institutes of Health
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference102 articles.
1. Exploiting the Ref-1–APE1 node in cancer signaling and other diseases: from bench to clinic;Shah;NPJ: Precis. Oncol.,2017
2. Base excision repair: a critical player in many games;Wallace;DNA Repair (Amst),2014
3. Uncoupling of the base excision and nucleotide incision repair pathways reveals their respective biological roles;Ishchenko;Proc. Natl. Acad. Sci. U.S.A.,2006
4. Molecular snapshots of APE1 proofreading mismatches and removing DNA damage;Whitaker;Nat. Commun.,2018
5. The major human AP endonuclease (Ape1) is involved in the nucleotide incision repair pathway;Gros;Nucleic. Acids Res.,2004
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inhibitors of APE1 redox and ATM synergistically sensitize osteosarcoma cells to ionizing radiation by inducing ferroptosis;International Immunopharmacology;2024-09
2. Construction of Multiply Guaranteed DNA Sensors for Biological Sensing and Bioimaging Applications;ChemBioChem;2024-07-12
3. Mechanisms of traditional Chinese medicine overcoming of radiotherapy resistance in breast cancer;Frontiers in Oncology;2024-06-27
4. Mendelian randomization study and mediation analysis about the relation of inflammatory bowel disease and diabetic retinopathy: the further exploration of gut-retina axis;Frontiers in Endocrinology;2024-06-14
5. Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration;Archives of Pharmacal Research;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3